Should ethnicity serve as the basis for clinical trial design? Diversity and inclusiveness should remain the guiding principles for clinical trials.
Cooper
Richard S
RS
Department of Preventive Medicine and Epidemiology, Loyola Stritch School of Medicine, Maywood, IL 60153, USA. rcooper@lumc.edu
Psaty
Bruce M
BM
D001741:Black or African American; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000379:methods*; D005006:Ethnicity; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D006977:Hypertension, Renal; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000517:prevention & control*; D044469:Racial Groups
D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents